A61K 31/4545
Containing a six-membered ring with nitrogen as a ring hetero atom
Official title: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A61K31/4545 (Containing a six-membered ring with nitrogen as a ring hetero atom) appears on 2,601 US grants and 4,825 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,601
- Published applications
- 4,825
- Assignees
- 1,612
- Inventors
- 11,206
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 22 | 0 |
| 1999 | 23 | 0 |
| 2000 | 24 | 0 |
| 2001 | 37 | 13 |
| 2002 | 31 | 42 |
| 2003 | 30 | 40 |
| 2004 | 12 | 57 |
| 2005 | 17 | 59 |
| 2006 | 18 | 54 |
| 2007 | 18 | 68 |
| 2008 | 21 | 72 |
| 2009 | 30 | 78 |
| 2010 | 40 | 94 |
| 2011 | 40 | 116 |
| 2012 | 72 | 110 |
| 2013 | 87 | 208 |
| 2014 | 134 | 222 |
| 2015 | 174 | 285 |
| 2016 | 181 | 291 |
| 2017 | 229 | 294 |
| 2018 | 212 | 254 |
| 2019 | 194 | 243 |
| 2020 | 177 | 259 |
| 2021 | 148 | 253 |
| 2022 | 107 | 254 |
| 2023 | 102 | 234 |
| 2024 | 147 | 407 |
| 2025 | 135 | 465 |
| 2026 | 122 | 353 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral liquid formulation of apixaban6 Oct 2026US 12,751,947 B2Liqmeds Worldwide Limited
- CCR6 receptor modulators6 Oct 2026US 12,753,168 B2Idorsia Pharmaceuticals Ltd
- LOX enzyme inhibiting methods and compositions29 Sep 2026US 12,746,243 B2Anovia Biosciences, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Potent and selective inhibitors of IRAK429 Sep 2026US 12,747,228 B2Dana-Farber Cancer Institute, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors8 Oct 2026US 2026/0306505 A1BioAxone BioSciences, Inc.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010
- 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof124US 8,450,340 B2Samumed, LLC · 2013
- Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom119US 7,425,292 B2Monosol Rx, LLC · 2008
- Modulators of ATP-binding cassette transporters116US 7,741,321 B2Vertex Pharmaceuticals Incorporated · 2010
- Piperidin-4-yl azetidine derivatives as JAK1 inhibitors113US 8,765,734 B2Incyte Corporation · 2014